Susquehanna International Group’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.83M | Sell |
185,669
-58,384
| -24% | -$2.15M | ﹤0.01% | 1015 |
|
|
2025
Q1 | $8.63M | Buy |
244,053
+97,865
| +67% | +$3.46M | ﹤0.01% | 734 |
|
|
2024
Q4 | $6.39M | Buy |
146,188
+91,518
| +167% | +$4M | ﹤0.01% | 952 |
|
|
2024
Q3 | $2.48M | Buy |
54,670
+16,906
| +45% | +$767K | ﹤0.01% | 1665 |
|
|
2024
Q2 | $1.47M | Sell |
37,764
-34,873
| -48% | -$1.35M | ﹤0.01% | 2102 |
|
|
2024
Q1 | $2.34M | Sell |
72,637
-76,015
| -51% | -$2.45M | ﹤0.01% | 1638 |
|
|
2023
Q4 | $4.26M | Sell |
148,652
-93,820
| -39% | -$2.69M | ﹤0.01% | 1268 |
|
|
2023
Q3 | $6.71M | Buy |
242,472
+52,552
| +28% | +$1.45M | ﹤0.01% | 918 |
|
|
2023
Q2 | $5.08M | Sell |
189,920
-116,903
| -38% | -$3.13M | ﹤0.01% | 1132 |
|
|
2023
Q1 | $6.65M | Buy |
306,823
+250,484
| +445% | +$5.43M | ﹤0.01% | 944 |
|
|
2022
Q4 | $1.34M | Sell |
56,339
-58,259
| -51% | -$1.39M | ﹤0.01% | 2000 |
|
|
2022
Q3 | $2.26M | Buy |
114,598
+94,959
| +484% | +$1.87M | ﹤0.01% | 1551 |
|
|
2022
Q2 | $383K | Sell |
19,639
-35,382
| -64% | -$690K | ﹤0.01% | 3678 |
|
|
2022
Q1 | $1.4M | Sell |
55,021
-21,335
| -28% | -$544K | ﹤0.01% | 2426 |
|
|
2021
Q4 | $1.92M | Buy |
76,356
+3,910
| +5% | +$98.4K | ﹤0.01% | 2024 |
|
|
2021
Q3 | $1.99M | Buy |
72,446
+34,379
| +90% | +$946K | ﹤0.01% | 1973 |
|
|
2021
Q2 | $1.21M | Sell |
38,067
-147,884
| -80% | -$4.69M | ﹤0.01% | 2725 |
|
|
2021
Q1 | $8.53M | Buy |
185,951
+171,148
| +1,156% | +$7.85M | ﹤0.01% | 878 |
|
|
2020
Q4 | $586K | Buy |
14,803
+6,361
| +75% | +$252K | ﹤0.01% | 3232 |
|
|
2020
Q3 | $294K | Buy |
+8,442
| New | +$294K | ﹤0.01% | 3545 |
|
|
2020
Q2 | – | Sell |
-27,394
| Closed | -$600K | – | 4816 |
|
|
2020
Q1 | $600K | Buy |
+27,394
| New | +$600K | ﹤0.01% | 2671 |
|